Oncologic immunomodulatory agents in patients with cancer and COVID-19
Abstract Corticosteroids, anti-CD20 agents, immunotherapies, and cytotoxic chemotherapy are commonly used in the treatment of patients with cancer. It is unclear how these agents affect patients with cancer who are infected with SARS-CoV-2. We retrospectively investigated associations between SARS-C...
Main Authors: | Justin Jee, Aaron J. Stonestrom, Sean Devlin, Teresa Nguyentran, Beatriz Wills, Varun Narendra, Michael B. Foote, Melissa Lumish, Santosha A. Vardhana, Stephen M. Pastores, Neha Korde, Dhwani Patel, Steven Horwitz, Michael Scordo, Anthony F. Daniyan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-84137-5 |
Similar Items
-
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
by: Jasmine Davda, et al.
Published: (2019-04-01) -
The immunomodulatory effects of probiotics
by: Omakobia, Michael
Published: (2015) -
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
by: Melissa Lumish, et al.
Published: (2021-01-01) -
Bioactive Immunomodulatory Compounds: A Novel Combinatorial Strategy for Integrated Medicine in Oncology? BAIC Exposure in Cancer Cells
by: Bruna Corradetti PhD, et al.
Published: (2019-08-01) -
Immunomodulatory activity of Fungal Immunomodulatory Proteins
by: Che-Jung, et al.
Published: (2006)